NVAX Stock Has a Bullish Case Based on Opinion Not Fact
Conventional wisdom suggests that if Novavax gets an EUA for its Covid-19 vaccine, it will be bullish for NVAX stock.
South Africa United States South African Novavax Covid World Health Organization Drug Administration
Source: investorplace.com